Conmed (CNMD) Return on Capital Employed (2011 - 2026)
Conmed (CNMD) reported Return on Capital Employed of 5.53% for Q1 2026, down 345.0% on a YoY basis from 2.26% in Q1 2025, and up 8.22% quarter-over-quarter from 5.11% in Q4 2025.
Conmed (CNMD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Conmed has reported Return on Capital Employed for 16 years, with the latest figure at 5.53% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 345.0% year-over-year to 5.53%; the trailing twelve-month figure through Mar 2026 stood at 5.53% (down 345.0% YoY), and the FY2025 full-year result was 5.13%, down 476.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 5.53%, up from 5.11% in the prior quarter.
- The five-year high for Return on Capital Employed was 9.85% in Q4 2024, with the low at 3.03% in Q1 2023.
- Historically, Return on Capital Employed has averaged 6.3% across 5 years, with a median of 6.02% in 2023.
- Annual changes were most pronounced in 2024 — Return on Capital Employed soared 625 bps — and 2025, when it plunged 475 bps.
- Conmed's Return on Capital Employed stood at 3.51% in 2022, then surged by 72 bps to 6.02% in 2023, then jumped by 64 bps to 9.85% in 2024, then tumbled by 48 bps to 5.11% in 2025, then climbed by 8 bps to 5.53% in 2026.
- The last three Return on Capital Employed figures came in at 5.53% (Q1 2026), 5.11% (Q4 2025), and 5.89% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Conmed | 994.72 Mn | 959.69 Mn | 183.45 Mn | 5.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.53% |
| Dec 31, 2025 | 5.11% |
| Sep 30, 2025 | 5.89% |
| Jun 30, 2025 | 8.54% |
| Mar 31, 2025 | 8.98% |
| Dec 31, 2024 | 9.85% |
| Sep 30, 2024 | 9.81% |
| Jun 30, 2024 | 8.01% |
| Mar 31, 2024 | 7.10% |
| Dec 31, 2023 | 6.02% |
| Sep 30, 2023 | 3.56% |
| Jun 30, 2023 | 3.21% |
| Mar 31, 2023 | 3.03% |
| Dec 31, 2022 | 3.51% |
| Sep 30, 2022 | 5.49% |
| Jun 30, 2022 | 6.41% |
| Mar 31, 2022 | 7.06% |
| Dec 31, 2021 | 7.02% |
| Sep 30, 2021 | 6.17% |
| Jun 30, 2021 | 6.42% |